Physician profile
Michael Anderson
NPI 1487217519
$458.74
in general payments reported to CMS, 2019-2025
8 companies · $45.07 in 2025
The $45.07 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $72.68 · 2022: $24.61 · 2023: $65.54 · 2024: $251 · 2025: $45.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $148.65 | 2024 | Xarelto, Spravato |
| Corium, LLC | $90.41 | 2022-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $85.42 | 2023-2024 | Qelbree, Qelbree |
| E.R. Squibb & Sons, L.L.C. | $45.07 | 2025 | Cobenfy |
| Greenwich Biosciences, INC. | $34.38 | 2020 | |
| Aprecia Pharmaceuticals, LLC | $21.35 | 2020 | |
| Aquestive Therapeutics, INC. | $16.95 | 2020 | |
| Neos Therapeutics, LP | $16.51 | 2023 | Cotempla Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.